Ontology highlight
ABSTRACT: Objective
To investigate the feasibility of assessing the efficacy of manual lymphatic drainage (MLD), a method for lymphedema (LE) management, by using near-infrared (NIR) fluorescence imaging.Design
Exploratory pilot study.Setting
Primary care unit.Participants
Subjects (N=10; age, 18-68y) with a diagnosis of grade I or II LE and 12 healthy control subjects (age, 22-59y).Intervention
Indocyanine green (25 ?g in 0.1 mL each) was injected intradermally in bilateral arms or legs of subjects. Diffused excitation light illuminated the limbs, and NIR fluorescence images were collected by using custom-built imaging systems. Subjects received MLD therapy, and imaging was performed pre- and posttherapy.Main outcome measures
Apparent lymph velocities and periods between lymphatic propulsion events were computed from fluorescence images. Data collected pre- and post-MLD were compared and evaluated for differences.Results
By comparing pre-MLD lymphatic contractile function against post-MLD lymphatic function, results showed that average apparent lymph velocity increased in both the symptomatic (+23%) and asymptomatic (+25%) limbs of subjects with LE and control limbs (+28%) of healthy subjects. The average lymphatic propulsion period decreased in symptomatic (-9%) and asymptomatic (-20%) limbs of subjects with LE, as well as in control limbs (-23%).Conclusions
We showed that NIR fluorescence imaging could be used to quantify immediate improvement of lymphatic contractile function after MLD.
SUBMITTER: Tan IC
PROVIDER: S-EPMC3109491 | biostudies-literature | 2011 May
REPOSITORIES: biostudies-literature
Archives of physical medicine and rehabilitation 20110501 5
<h4>Objective</h4>To investigate the feasibility of assessing the efficacy of manual lymphatic drainage (MLD), a method for lymphedema (LE) management, by using near-infrared (NIR) fluorescence imaging.<h4>Design</h4>Exploratory pilot study.<h4>Setting</h4>Primary care unit.<h4>Participants</h4>Subjects (N=10; age, 18-68y) with a diagnosis of grade I or II LE and 12 healthy control subjects (age, 22-59y).<h4>Intervention</h4>Indocyanine green (25 μg in 0.1 mL each) was injected intradermally in ...[more]